UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 245

Sortiert nach

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review

CNS drugs, 2020-04, Vol.34 (4), p.337-365

2020

Volltextzugriff (PDF)

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

Neuropsychopharmacology (New York, N.Y.), 2017-08, Vol.42 (9), p.1752-1765

2017

Volltextzugriff (PDF)

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

Harm reduction journal, 2020-05, Vol.17 (1), p.26-7, Article 26

2020

Volltextzugriff (PDF)

Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

Harm reduction journal, 2020-06, Vol.17 (1), p.37-12, Article 37

2020

Volltextzugriff (PDF)

The impact of changes in opioid dependency treatment upon COVID-19 transmission in Sydney, Australia: a retrospective longitudinal observational study

BMC public health, 2024-02, Vol.24 (1), p.349-349, Article 349

2024

Volltextzugriff (PDF)

Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study

PloS one, 2024-02, Vol.19 (2), p.e0297092-e0297092

2024

Volltextzugriff (PDF)

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)

Harm reduction journal, 2022-07, Vol.19 (1), p.1-88, Article 88

2022

Volltextzugriff (PDF)

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

The Lancet. Public health, 2018-07, Vol.3 (7), p.e341-e350

2018

Volltextzugriff (PDF)

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

PloS one, 2022-10, Vol.17 (10), p.e0275371-e0275371

2022

Volltextzugriff (PDF)

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

The Lancet (British edition), 2010-05, Vol.375 (9729), p.1885-1895

2010

Volltextzugriff (PDF)

Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study

BMJ open, 2021-05, Vol.11 (5), p.e044696-e044696

2021

Volltextzugriff (PDF)

Providing take home naloxone needs to be improved to prevent opioid overdose deaths

Medical journal of Australia, 2020-04, Vol.212 (7), p.307-308

Lintzeris, Nicholas

2020

Volltextzugriff (PDF)

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol

BMC psychiatry, 2024-03, Vol.24 (1), p.175-175, Article 175

2024

Volltextzugriff (PDF)

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)

Harm reduction journal, 2024-05, Vol.21 (1), p.104-11, Article 104

2024

Volltextzugriff (PDF)

Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost

BMJ open, 2024-08, Vol.14 (8), p.e082553

2024

Volltextzugriff (PDF)

Diagnosing and managing patients with chronic pain who develop prescription opioid use disorder: A scoping review of general practitioners' experience

Australian journal of general practice, 2022-10, Vol.51 (10), p.804-811

2022

Volltextzugriff (PDF)

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

Substance abuse treatment, prevention and policy, 2022-10, Vol.17 (1), p.1-12, Article 67

2022

Volltextzugriff (PDF)

Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review

Journal of cannabis research, 2024-03, Vol.6 (1), p.15-15, Article 15

2024

Volltextzugriff (PDF)

Real-time monitoring of Schedule 8 medicines in Australia: evaluation is essential

Medical journal of Australia, 2013-02, Vol.198 (2), p.80-81

2013

Volltextzugriff (PDF)

Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study

The Lancet. Psychiatry, 2015-04, Vol.2 (4), p.314-322

2015

Volltextzugriff (PDF)

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study

BMJ open, 2020-07, Vol.10 (7), p.e034389-e034389

2020

Volltextzugriff (PDF)

Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study

EClinicalMedicine, 2020-11, Vol.28, p.100592-100592, Article 100592

2020

Volltextzugriff (PDF)

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey

Journal of cannabis research, 2023-09, Vol.5 (1), p.35-35, Article 35

2023

Volltextzugriff (PDF)

The characteristics of a cohort who tamper with prescribed and diverted opioid medications

Journal of substance abuse treatment, 2015-11, Vol.58, p.51-61

2015

Volltextzugriff (PDF)

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol

BMC psychiatry, 2018-05, Vol.18 (1), p.140-14, Article 140

2018

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(236)

Publikationsform

Sprache

Englisch
(244)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

The impact of changes in opioid dependency treatment upon COVID-19 transmission in Sydney, Australia: a retrospective longitudinal observational study

Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study

Providing take home naloxone needs to be improved to prevent opioid overdose deaths

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)

Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost

Diagnosing and managing patients with chronic pain who develop prescription opioid use disorder: A scoping review of general practitioners' experience

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review

Real-time monitoring of Schedule 8 medicines in Australia: evaluation is essential

Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study

Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey

The characteristics of a cohort who tamper with prescribed and diverted opioid medications

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol

Suchergebnisse filtern